Emerging Biopharma

graphic image of different colored hands shaking
Biotech

Crescent inks $80M Kelun deal, adding ADC to mix with bispecific

The deal positions Crescent to test a Kelun ADC in combination with its PD-1xVEGF bispecific.
Nick Paul Taylor Dec 4, 2025 9:50am
Winding 3D road with dollar bills

Protego tucks $130M series B into its fold

Dec 1, 2025 6:00am
Technology background with national flag of the United States

Federal commission warns that US is losing innovative edge

Nov 25, 2025 3:47pm
Sunrise over foggy forest in Tuscany Italy

Versant's Dayra dawns with $50M Biogen pact

Nov 24, 2025 10:28am
Philadelphia Pennsylvania in autumn overlooking Benjamin Franklin Parkway

Lilly picks Philadelphia for newest Gateway Labs site

Nov 19, 2025 6:45am
china chinese Asia

Bayer opens Beijing incubator, names initial occupants

Nov 17, 2025 10:18am
More News

Braveheart, with Biogen CEO on board, rallies $185M series A

Nov 5, 2025 7:51am

In vivo gene editing biotech blossoms from Jennifer Doudna's lab

Nov 4, 2025 8:00am

Neok exits stealth with $75M to take bispecific ADCs into clinic

Nov 4, 2025 7:00am

Italian biotech raises $141M series B to fund eye gene therapies

Nov 3, 2025 3:00am